Severe, symptomatic, dose-limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases.

MLA

del Giglio, A., et al. “Severe, Symptomatic, Dose-Limiting Hypophosphatemia Induced by Hepatic Arterial Infusion of Recombinant Tumor Necrosis Factor in Patients with Liver Metastases.” Cancer (0008543X), vol. 67, no. 10, May 1991, pp. 2459–61. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=137791009&authtype=sso&custid=ns315887.

APA

del Giglio, A., Zukiwski, A. A., Ali, M. K., & Mavligit, G. M. (1991). Severe, symptomatic, dose-limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases. Cancer (0008543X), 67(10), 2459–2461.

Chicago

del Giglio, A, A A Zukiwski, M K Ali, and G M Mavligit. 1991. “Severe, Symptomatic, Dose-Limiting Hypophosphatemia Induced by Hepatic Arterial Infusion of Recombinant Tumor Necrosis Factor in Patients with Liver Metastases.” Cancer (0008543X) 67 (10): 2459–61. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=137791009&authtype=sso&custid=ns315887.